GeneDx Holdings (WGS) Income from Continuing Operations (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Income from Continuing Operations of 63319000.0 for Q1 2026, down 869.81% year-over-year from 8225259.17 in Q1 2025, and down 258.42% quarter-over-quarter from 17666000.0 in Q4 2025.
GeneDx Holdings (WGS) Income from Continuing Operations (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Income from Continuing Operations for 7 consecutive years, with 63319000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 869.81% year-over-year to 63319000.0; the TTM figure through Mar 2026 stood at 77764000.0 (down 101.74% YoY), while the FY2025 annual figure was 21021000.0, up 59.8% from the prior year.
- Income from Continuing Operations eased to 63319000.0 in Q1 2026 per WGS's latest filing, from 17666000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 10809000.0 in Q2 2025 and bottomed at 308719000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 50661176.47 across 5 years, with a median of 29163000.0 in 2024.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations soared 137.06% — and 2026, when it tumbled 869.81%.
- GeneDx Holdings' Income from Continuing Operations stood at 308719000.0 in 2022, then soared by 91.66% to 25758000.0 in 2023, then jumped by 121.19% to 5457000.0 in 2024, then tumbled by 423.73% to 17666000.0 in 2025, then sank by 258.42% to 63319000.0 in 2026.
- Business Quant data shows WGS's Income from Continuing Operations at 63319000.0 in Q1 2026, 17666000.0 in Q4 2025, and 7588000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | GeneDx Holdings | 2.65 Bn | 2.52 Bn | 78.24 Mn | -17.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.74 Mn |
| Mar 31, 2026 | -63.32 Mn |
| Dec 31, 2025 | -17.67 Mn |
| Sep 30, 2025 | -7.64 Mn |
| Jun 30, 2025 | 10.81 Mn |
| Mar 31, 2025 | -6.53 Mn |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | -8.31 Mn |
| Jun 30, 2024 | -29.16 Mn |
| Mar 31, 2024 | -20.22 Mn |
| Dec 31, 2023 | -25.77 Mn |
| Sep 30, 2023 | -42.29 Mn |
| Jun 30, 2023 | -46.72 Mn |
| Mar 31, 2023 | -60.99 Mn |
| Dec 31, 2022 | -308.71 Mn |
| Sep 30, 2022 | -77.58 Mn |
| Jun 30, 2022 | -85.74 Mn |
| Mar 31, 2022 | -76.90 Mn |
| Dec 31, 2021 | -40.19 Mn |
| Sep 30, 2021 | 32.73 Mn |